申请人:OTSUKA PHARMACEUTICAL FACTORY, INC.
公开号:EP0740935A1
公开(公告)日:1996-11-06
The present invention provides an analgesic effect enhancing preparation capable of enhancement of the effect of analgesics, the preparation comprising as an active ingredient the following amino acid composition (%); leucine 8.0 - 16.0, isoleucine 4.0 - 9.0, valine 4.0 - 9.0, lysine 6.0 - 13.0, threonine 3.0 - 6.0, tryptophan 1.0 - 2.0, methionine 2.0 - 5.0, cysteine o.5 - 2.0, phenylalanine 3.0 - 7.0, tyrosine 0.2 - 1.0, histidine 2.0 - 5.0, arginine 30.0 - 60.0, alanine 0.5 - 2.0, aminoacetic acid 0.5 - 2.0, serine 0.2 - 1.0, proline 0.5 - 2.0, aspartic acid 0.1 - 0.5 and glutamic acid 0.1 - 0.5, calculated as free amino acids.
The analgesic effect enhancing preparation of the present invention potentiates analgesic effect of various analgesics.
本发明提供了一种能够增强镇痛药效果的镇痛效果增强制剂,该制剂作为有效成 分包括以下氨基酸组成(%);亮氨酸 8.0 - 16.0,异亮氨酸 4.0 - 9.0,缬氨酸 4.0 - 9.0,赖氨酸 6.0 - 13.0,苏氨酸 3.0 - 6.0,色氨酸 1.0 - 2.0,蛋氨酸 2.0 - 5.0,半胱氨酸 o.5- 2.0, 苯丙氨酸 3.0 - 7.0, 酪氨酸 0.2 - 1.0, 组氨酸 2.0 - 5.0, 精氨酸 30.0 - 60.0, 丙氨酸 0.5 - 2.0, 氨基乙酸 0.5 - 2.0, 丝氨酸 0.2 - 1.0, 脯氨酸 0.5 - 2.0, 天门冬氨酸 0.1 - 0.5 和谷氨酸 0.1 - 0.5(以游离氨基酸计算)。
本发明的镇痛效果增强制剂可增强各种镇痛药的镇痛效果。